- ADx NeuroSciences’ review of 2021
- ADx will be present at the upcoming virtual AAIC 2020
- ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
- Present at CTAD 2019
- ADx receives funding from Bill Gates for developing blood biomarkers